Citadel Advisors’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $491K | Buy |
|
|||||
|
2025
Q2 | $239K | Sell |
|
|||||
|
2025
Q1 | $215K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $218K | Buy |
|
|||||
|
2024
Q1 | – | Hold |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $568K | Buy |
|
|||||
|
2023
Q2 | $661K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $543K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $175K | Sell |
|
|||||
|
2022
Q1 | $531K | Buy |
|
|||||
|
2021
Q4 | – | Hold |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $564K | Sell |
|
|||||
|
2021
Q1 | $643K | Buy |
|
|||||
|
2020
Q4 | $638K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $203K | Buy |
|
|||||
|
2019
Q4 | $150K | Sell |
|
|||||
|
2019
Q3 | $199K | Buy |
|
|||||
|
2019
Q2 | $111K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $205K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $188K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $138K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $238K | Sell |
|
|||||
|
2015
Q3 | $403K | Buy |
|
|||||
|
2015
Q2 | $444K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $356K | Buy |
|
|||||
|
2014
Q2 | $312K | Sell |
|
|||||
|
2014
Q1 | $695K | Buy |
|
|||||
|
2013
Q4 | $345K | Buy |
|
|||||
|
2013
Q3 | $329K | Buy |
|